Hatfield, United Kingdom

James Thompson

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Generics (UK) Limited. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: James Thompson. Retrieved from https://idiyas.com/inventor/james-thompson-dmfi2xlr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0



Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: James Thompson - Innovator in Pharmaceutical Aerosol Compositions

Introduction

James Thompson is a notable inventor based in Hatfield, GB. He has made significant contributions to the field of pharmaceutical compositions, particularly in the development of aerosol formulations. His work focuses on improving inhalation therapies, which are crucial for patients with respiratory conditions.

Latest Patents

James holds 1 patent for his invention titled "Pharmaceutical aerosol compositions comprising fluticasone." This patent relates to suspension aerosol pharmaceutical compositions, processes to obtain them, and their use in inhalation therapy. His innovative approach aims to enhance the efficacy and delivery of medication to patients.

Career Highlights

James is currently employed at Generics (UK) Limited, where he continues to work on developing advanced pharmaceutical solutions. His expertise in aerosol compositions has positioned him as a valuable asset in the pharmaceutical industry.

Collaborations

James collaborates with his coworker, Paul Flanders, to further advance their research and development efforts in the field of inhalation therapies. Their combined knowledge and skills contribute to the success of their projects.

Conclusion

James Thompson's work in pharmaceutical aerosol compositions exemplifies innovation in the healthcare sector. His contributions are vital for improving treatment options for patients with respiratory issues.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…